The state-owned pharmaceutical firm HoldiPharma signed a partnership agreement with US-based Dawah Pharma to establish a joint venture for the manufacturing and export of pharmaceuticals and nutritional supplements to international markets, including North America and Europe.
Updated 5/28/2025 12:04:00 PM
The state-owned pharmaceutical firm HoldiPharma has received five offers from investment banks to manage the anticipated offerings of its subsidiaries, Chemical Industries Development (CID) and Misr Pharma, on the Egyptian Exchange (EGX).
Updated 9/18/2024 8:38:00 AM